These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 22392421

  • 1. A real-world evaluation of oral vancomycin for severe Clostridium difficile infection: implications for antibiotic stewardship programs.
    Le F, Arora V, Shah DN, Salazar M, Palmer HR, Garey KW.
    Pharmacotherapy; 2012 Feb; 32(2):129-34. PubMed ID: 22392421
    [Abstract] [Full Text] [Related]

  • 2. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.
    Harpe SE, Inocencio TJ, Pakyz AL, Oinonen MJ, Polk RE.
    Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522
    [Abstract] [Full Text] [Related]

  • 3. Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy.
    Jardin CG, Palmer HR, Shah DN, Le F, Beyda ND, Jiang Z, Garey KW.
    J Hosp Infect; 2013 Sep; 85(1):28-32. PubMed ID: 23834988
    [Abstract] [Full Text] [Related]

  • 4. Clostridium difficile infection in older adults: a review and update on its management.
    Kee VR.
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
    [Abstract] [Full Text] [Related]

  • 5. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.
    Zar FA, Bakkanagari SR, Moorthi KM, Davis MB.
    Clin Infect Dis; 2007 Aug 01; 45(3):302-7. PubMed ID: 17599306
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The Addition of Intravenous Metronidazole to Oral Vancomycin is Associated With Improved Mortality in Critically Ill Patients With Clostridium difficile Infection.
    Rokas KE, Johnson JW, Beardsley JR, Ohl CA, Luther VP, Williamson JC.
    Clin Infect Dis; 2015 Sep 15; 61(6):934-41. PubMed ID: 26024909
    [Abstract] [Full Text] [Related]

  • 8. Fidaxomicin: the newest addition to the armamentarium against Clostridium difficile infections.
    Lancaster JW, Matthews SJ.
    Clin Ther; 2012 Jan 15; 34(1):1-13. PubMed ID: 22284993
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Epidemiology, diagnosis and treatment of Clostridium difficile infection.
    Bassetti M, Villa G, Pecori D, Arzese A, Wilcox M.
    Expert Rev Anti Infect Ther; 2012 Dec 15; 10(12):1405-23. PubMed ID: 23253319
    [Abstract] [Full Text] [Related]

  • 11. Systemic absorption of oral vancomycin in patients with Clostridium difficile infection.
    Rao S, Kupfer Y, Pagala M, Chapnick E, Tessler S.
    Scand J Infect Dis; 2011 May 15; 43(5):386-8. PubMed ID: 21198337
    [Abstract] [Full Text] [Related]

  • 12. Clostridium difficile infection in the "oldest" old: clinical outcomes in patients aged 80 and older.
    Cober ED, Malani PN.
    J Am Geriatr Soc; 2009 Apr 15; 57(4):659-62. PubMed ID: 19392957
    [Abstract] [Full Text] [Related]

  • 13. Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1/BI/027 setting.
    Venugopal AA, Riederer K, Patel SM, Szpunar S, Jahamy H, Valenti S, Shemes SP, Khatib R, Johnson LB.
    Scand J Infect Dis; 2012 Apr 15; 44(4):243-9. PubMed ID: 22077148
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies.
    Parmar SR, Bhatt V, Yang J, Zhang Q, Schuster M.
    J Oncol Pharm Pract; 2014 Jun 15; 20(3):172-82. PubMed ID: 23804627
    [Abstract] [Full Text] [Related]

  • 16. Economic impact of Clostridium difficile infection in a multihospital cohort of academic health centers.
    Pakyz A, Carroll NV, Harpe SE, Oinonen M, Polk RE.
    Pharmacotherapy; 2011 Jun 15; 31(6):546-51. PubMed ID: 21923438
    [Abstract] [Full Text] [Related]

  • 17. Treatment of Clostridium difficile infection in a French university hospital.
    Khanafer N, Blais L, Barbut F, Hirschel B, Vanhems P.
    Scand J Gastroenterol; 2015 Jun 15; 50(10):1253-60. PubMed ID: 25877477
    [Abstract] [Full Text] [Related]

  • 18. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.
    Al-Nassir WN, Sethi AK, Nerandzic MM, Bobulsky GS, Jump RL, Donskey CJ.
    Clin Infect Dis; 2008 Jul 01; 47(1):56-62. PubMed ID: 18491964
    [Abstract] [Full Text] [Related]

  • 19. Comparison of treatment outcomes with vancomycin alone versus combination therapy in severe Clostridium difficile infection.
    Bass SN, Bauer SR, Neuner EA, Lam SW.
    J Hosp Infect; 2013 Sep 01; 85(1):22-7. PubMed ID: 23876778
    [Abstract] [Full Text] [Related]

  • 20. High frequency of nonadherence to Clostridium difficile treatment guidelines.
    McEllistrem MC, McGraw M, Sahud AG, Chan-Tompkins NH, Goswami R, Bhanot N.
    South Med J; 2014 Sep 01; 107(9):597-9. PubMed ID: 25188627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.